Financial Results - Standalone (₹ in Lacs)

Quarterly Performance:

  • Quarter Ended September 30, 2026: Revenue from Operations: 1,698.62, Other Income: 104.50, Total Income: 1,803.13, Profit Before Tax: 170.20, Net Profit After Tax: 84.71
  • Quarter Ended June 30, 2026: Revenue from Operations: 1,413.94, Other Income: 5.54, Total Income: 1,419.48, Profit Before Tax: 86.92, Net Profit After Tax: 66.28
  • Quarter Ended September 30, 2025: Revenue from Operations: 1,301.66, Other Income: 13.39, Total Income: 1,315.05, Profit Before Tax: 302.58, Net Profit After Tax: 224.24

Half-Yearly Performance:

  • Half-Year Ended September 30, 2026: Revenue from Operations: 3,112.56, Other Income: 110.04, Total Income: 3,222.60, Profit Before Tax: 256.83, Net Profit After Tax: 150.98
  • Half-Year Ended September 30, 2025: Revenue from Operations: 2,543.52, Other Income: 27.17, Total Income: 2,570.69, Profit Before Tax: 521.24, Net Profit After Tax: 297.12

Earnings Per Share (Standalone):

  • Basic and Diluted EPS: Q2 FY27: 0.38, Q1 FY27: 0.30, Q2 FY26: 1.01, H1 FY27: 0.68, H1 FY26: 1.34

Financial Results - Consolidated (₹ in Lacs)

Quarterly Performance:

  • Quarter Ended September 30, 2026: Revenue from Operations: 1,719.15, Other Income: 155.34, Total Income: 1,874.49, Profit Before Tax: 186.96, Net Profit After Tax: 110.21
  • Quarter Ended June 30, 2026: Revenue from Operations: 1,427.97, Other Income: 5.54, Total Income: 1,433.51, Profit Before Tax: 33.86, Net Profit After Tax: 18.76
  • Quarter Ended September 30, 2025: Revenue from Operations: 1,310.90, Other Income: 13.39, Total Income: 1,324.29, Profit Before Tax: 150.92, Net Profit After Tax: 86.86

Half-Yearly Performance:

  • Half-Year Ended September 30, 2026: Revenue from Operations: 3,147.12, Other Income: 160.88, Total Income: 3,308.00, Profit Before Tax: 220.82, Net Profit After Tax: 128.97
  • Half-Year Ended September 30, 2025: Revenue from Operations: 2,562.06, Other Income: 27.17, Total Income: 2,589.23, Profit Before Tax: 298.91, Net Profit After Tax: 220.57

Earnings Per Share (Consolidated):

  • Basic and Diluted EPS: Q2 FY27: 0.50, Q1 FY27: 0.08, Q2 FY26: 0.45, H1 FY27: 0.58, H1 FY26: 1.14

Assets and Liabilities Position (₹ in Lacs)

Standalone as of September 30, 2026:

  • Total Assets: 19,380.01
  • Non-Current Assets: 15,923.87 (including Fixed Assets: 7,131.34, Capital Work-in-Progress: 1,616.23, Intangible Assets: 4,772.15)
  • Current Assets: 3,456.13
  • Total Equity: 9,406.33
  • Non-Current Liabilities: 6,571.03
  • Current Liabilities: 3,402.65

Consolidated as of September 30, 2026:

  • Total Assets: 19,718.20
  • Non-Current Assets: 16,236.50
  • Current Assets: 3,481.70
  • Total Equity: 9,444.75
  • Non-Current Liabilities: 6,864.33
  • Current Liabilities: 3,409.12

Cash Flow Statements (₹ in Lacs)

Standalone Half-Year Ended September 30, 2026:

  • Net Cash from Operating Activities: 858.44
  • Net Cash Used in Investing Activities: (1,873.47)
  • Net Cash from Financing Activities: 1,162.68
  • Net Increase in Cash: 147.64
  • Closing Cash Balance: 277.95

Consolidated Half-Year Ended September 30, 2026:

  • Net Cash from Operating Activities: 841.16
  • Net Cash Used in Investing Activities: (1,803.23)
  • Net Cash from Financing Activities: 1,109.68
  • Net Increase in Cash: 147.61
  • Closing Cash Balance: 291.16

Key Notes and Additional Information

1. The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors on November 11, 2026.

2. The figures for the quarter ended March 31, 2026 are balancing figures between audited full-year figures and published year-to-date figures up to the 3rd quarter.

3. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of Companies Act, 2013 and Regulation 33 of SEBI LODR Regulations, 2015.

4. The consolidated results include results of all subsidiaries: Vivobio Labs Private Limited, Vivobio Discovery Services Private Limited, Surlogic Life Consultancy Private Limited, and Vivobio Consulting Services Private Limited (Formerly Donakanti Consulting Services Private Limited).

5. The company operates in a single segment: Biotechnology.

6. The financial results are available on the stock exchange website www.bseindia.com and company's website www.vivobio.com.

7. Previous year's/period's figures have been rearranged/regrouped wherever necessary.

Auditor Review

Statutory Auditors M/s. P. Murali & Co., Chartered Accountants issued limited review reports for both standalone and consolidated financial results, stating that nothing has come to their attention that causes them to believe that the statements contain any material misstatement.